Abstract
Abstract—High prevalence of the central nervous system disorders necessitates novel methods and approaches for their pharmacological correction. Traditionally used rodent models are limited by high costs of research, complex maintenance and care, and long development. The use of alternative, aquatic model organisms, such as the zebrafish (Danio rerio), in translational neuroscience and medicine allows for fast efficient experimentation with easy maintenance, manipulations, and rapid development. Zebrafish are also sensitive to major classes of physiologically active agents, which makes this model indispensable for preclinical studies of a wide range of small molecules. The similarity of neurochemical systems, the presence of major neurotransmitters, a high degree of genetic and physiological homology with humans, the availability of both larval and adult fish models, and embryonic transparency provide multiple possibilities for using this organism to model CNS pathologies and its genetic and environmental causes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
